KeyCorp heads into its May 14 Q1 earnings report with analysts upgrading targets, a strategic investor quietly trimming, and short sellers keeping their distance.
The most notable positioning story is not in the borrow market — it's in the ownership register. The Bank of Nova Scotia, KeyCorp's largest shareholder with roughly 14.7% of shares, has been selling steadily since February. Four separate open-market sales since mid-February total more than $19 million in value. The pace is measured rather than panicked, and Scotiabank remains by far the largest holder, but the ongoing reduction is worth watching as Key approaches the print. Away from Scotiabank, the direction of institutional flow is broadly supportive: Vanguard, BlackRock, and State Street all added shares in their most recent reporting periods.
Short sellers are not pressing the thesis into earnings. At just under 2% of the free float, short interest is low by any standard. It fell sharply in mid-to-late April — shedding nearly 2.3 million shares over the week of April 23 — before drifting very slightly higher in early May. Borrow costs are well under 1%, and availability is wide, meaning there is no squeeze pressure and no friction for new shorts to enter if they wanted to. Options positioning corroborates the lack of urgency: the put/call ratio of 0.90 runs just below its 20-day average of 0.91, essentially neutral. Neither camp is loading up ahead of the announcement.
The analyst debate has tilted constructive since Q1 numbers crossed in April. Several firms raised price targets after the last print — Evercore ISI lifted its target to $26 from $24, Piper Sandler moved to $24 from $23, and RBC Capital raised to $24 from $22, all maintaining positive ratings. DA Davidson went further, bumping its Buy target to $27 as recently as May 4. The bull case centres on net interest income expansion: growing NIM and loan volume recovery are seen as the core re-rating catalyst. Against that, bears point to asset-quality risk, a concentrated middle-market commercial loan book, and a capital management picture that saw CET1 and tangible book value per share decline last quarter despite a headline EPS beat. JPMorgan, sitting at Neutral with a $22.50 target trimmed in early April, represents the cautious end of a generally positive but selective Street. The mean analyst target of roughly $25 compares to the current price of $21.60, leaving implied upside of around 16%.
The May 14 print is therefore a test of whether NIM expansion is tracking the trajectory analysts lifted targets for — and whether credit quality has held up well enough to quiet the capital concerns that have kept a meaningful portion of the Street on the sidelines.
See the live data behind this article on ORTEX.
Open KEY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
